Alprazolam tablets require a valid prescription from a DEA-registered US healthcare provider as a Schedule IV controlled substance for short-term management of generalized anxiety disorder or panic disorder. No private home arrival service or online platform can legally dispense them without a full medical evaluation, as prescription-free sales constitute federal felony distribution under 21 U.S.C. § 841.
Standard strengths (0.25mg, 0.5mg, 1mg, 2mg) demand synchronous HIPAA video confirmation of DSM-5 criteria via HAM-A>20, PDMP clearance, SUD exclusion, and lowest effective dose for shortest duration under 2025 DEA flexibilities ending 12/31/2025—post-2025 requires in-person exams or special registration with EPCS.
Anxiety: start 0.25-0.5mg TID max 4mg/day; panic: 0.5mg TID up to 10mg. Black box: abuse/dependence (30% tolerance by week 4), respiratory depression with opioids (OR 6-12), withdrawal seizures (15-25% abrupt >2mg)—taper 0.125mg q3d.
HAM-A screening + impairment docs.
Video consult (PDMP/DAST<3).
EPCS #30 tabs (0-2 refills).
C-IV signature delivery.
Weekly monitoring/taper.
Private services evade Ryan Haight—prosecutable diversion.